Abbott

Abbott

ABT
Dublin, Ireland· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

ABT · Stock Price

USD 86.30-19.16 (-18.17%)
Market Cap: $151.3B

Historical price data

Overview

Abbott Laboratories is a diversified healthcare giant with a mission to advance human health through accessible, innovative solutions across the care continuum. Its strategic achievements are anchored in market-leading franchises like the FreeStyle Libre continuous glucose monitoring system and the Alinity diagnostic platform, driving consistent growth. The company's strategy balances deep R&D investment in high-growth areas like diabetes and cardiovascular care with a disciplined focus on operational efficiency and geographic expansion, particularly in emerging markets. This approach has solidified its position as a mature, financially robust enterprise with a $179.44B market capitalization.

DiabetesCardiovascularNeurologyInfectious DiseaseNutritionOncology

Technology Platform

Abbott leverages multiple integrated technology platforms, including continuous glucose monitoring (CGM) sensor technology, high-throughput diagnostic assay systems (Alinity), and advanced medical device engineering for structural heart, electrophysiology, and neuromodulation.